SAR445877
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR445877, covering 2026-01-20 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer [Phase 1]